2.84
+0.05(+1.79%)
Currency In USD
| Previous Close | 2.79 |
| Open | 2.77 |
| Day High | 2.89 |
| Day Low | 2.73 |
| 52-Week High | 3.94 |
| 52-Week Low | 0.69 |
| Volume | 4.55M |
| Average Volume | 5.11M |
| Market Cap | 572.4M |
| PE | -5.26 |
| EPS | -0.54 |
| Moving Average 50 Days | 1.77 |
| Moving Average 200 Days | 1.67 |
| Change | 0.05 |
If you invested $1000 in Esperion Therapeutics, Inc. (ESPR) 10 years ago, it would be worth $59.65 as of September 13, 2025 at a share price of $2.84. Whereas If you bought $1000 worth of Esperion Therapeutics, Inc. (ESPR) shares 5 years ago, it would be worth $73.2 as of September 13, 2025 at a share price of $2.84.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Esperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidaemias
GlobeNewswire Inc.
Aug 29, 2025 12:00 PM GMT
– Bempedoic Acid Receives Strongest Endorsement from ESC/EAS Guidelines Based on Compelling and Practice-Changing Evidence – – Guideline Recognition of ‘Strike Early and Strike Strong’ Approach with Early Combination Lipid-Lowering Therapy Affirms Co
Esperion to Participate in Upcoming September Investor Conferences
GlobeNewswire Inc.
Aug 26, 2025 12:00 PM GMT
ANN ARBOR, Mich., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of September, which can be found on our investor relation
Esperion to Report Second Quarter 2025 Financial Results on August 5
GlobeNewswire Inc.
Jul 22, 2025 12:00 PM GMT
ANN ARBOR, Mich., July 22, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report second quarter 2025 financial results before the market opens on Tuesday, August 5, 2025. Following the release, management will host a webca